Patent · US Active

Chemotherapeutic pharmaceutical suspension for oral dosage

US12083222B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

ONCOSOL LIMITED · GB

Inventors

Sandip P. Mehta · Ahmedabad, IN
Manish Umrethia · Ahmedabad, IN
Jayanta Kumar MANDAL · Ahmedabad, IN

Key dates

Filing date	Aug 16, 2019
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Nov 27, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an anti-cancer active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the anti-cancer active pharmaceutical ingredient is selected from ibrutinib, nilotinib, dasatinib, sunitinib, sorafenib, erlotinib, and capecitabine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.